IL2 and type 1 diabetes mellitus: Therefore, the first step in our approach to T1D prevention was to determine the single doses of aldesleukin that increase Treg numbers within the physiological range, aiming to mimic the protection against T1D afforded by the risk-reducing alleles of the IL-2 pathway.